Does Rallies show Form 4 insider transactions for KIDS?

Yes. Rallies tracks KIDS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is KIDS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for KIDS. It does not provide personalized investment advice.

KIDS (OrthoPediatrics Corp. Common Stock) Stock Analysis - Insider Trades

OrthoPediatrics Corp. Common Stock (KIDS) is a publicly traded Healthcare sector company. As of May 21, 2026, KIDS trades at $18.50 with a market cap of $465.93M and a P/E ratio of -10.83. KIDS moved +1.32% today. Year to date, KIDS is +1.82%; over the trailing twelve months it is -19.18%. Its 52-week range spans $14.42 to $32.00. Analyst consensus is strong buy with an average price target of $24.63. Rallies surfaces KIDS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading KIDS stock inside the company?

Recent KIDS insider activity includes Hauser Joseph W sold 8.60K, Hite Fred sold 12.99K, Bailey David R sold 19.54K, Odle Gregory A sold 8.43K, and Gerritzen Daniel J sold 8.61K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

KIDS Key Metrics

Key financial metrics for KIDS
Metric	Value
Price	$18.50
Market Cap	$465.93M
P/E Ratio	-10.83
EPS	$-1.69
Dividend Yield	0.00%
52-Week High	$32.00
52-Week Low	$14.42
Volume	5
Avg Volume	0
Revenue (TTM)	$236.35M
Net Income	$-39.65M
Gross Margin	73.05%

Recent KIDS Insider Trades

Hauser Joseph W sold 8.60K (~$148.28K) on Mar 16, 2026.
Hite Fred sold 12.99K (~$224.13K) on Mar 16, 2026.
Bailey David R sold 19.54K (~$336.98K) on Mar 16, 2026.
Odle Gregory A sold 8.43K (~$145.47K) on Mar 16, 2026.
Gerritzen Daniel J sold 8.61K (~$148.59K) on Mar 16, 2026.

Latest KIDS News

OrthoPediatrics Q1 Revenue Up 13% to $59.4M, Guidance Raised to $263–$267M — Apr 30, 2026
OrthoPediatrics Rises to Zacks Rank #2 after 7.8% EPS Revision and 32.7% Upside — Mar 3, 2026
OrthoPediatrics Achieves 17% Q4 Growth, $10M Cash Flow and FDA Approval for 3P Small Mini — Feb 27, 2026
OrthoPediatrics Q4: 17% Revenue Growth to $61.6M, Sports Medicine Sales +118.5% — Feb 27, 2026

KIDS Analyst Consensus

8 analysts cover KIDS: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.63.

Common questions about KIDS

Who is trading KIDS stock inside the company?: Recent KIDS insider activity includes Hauser Joseph W sold 8.60K, Hite Fred sold 12.99K, Bailey David R sold 19.54K, Odle Gregory A sold 8.43K, and Gerritzen Daniel J sold 8.61K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for KIDS?: Yes. Rallies tracks KIDS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is KIDS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for KIDS. It does not provide personalized investment advice.